Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

There is still no established treatment regimen for eyes with inflammatory choroidal neovascularisation (iCNV) treated with intravitreal anti-vascular endothelial growth factor (VEGF) injections. This study compared the 24-month outcomes of two treatment regimens of anti-VEGF injections in eyes with iCNV.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Br J Ophthalmol

Title: The British journal of ophthalmology

Publisher: BMJ

ISSN (Electronic): 1468-2079

ISSN (Print): 0007-1161

Publication date (Electronic): August 2020

Volume: 104

Issue: 8

Affiliations

[1 ] Eye Clinic, Department of Biomedical and Clinical Science "L. Sacco", Luigi Sacco Hospital, University of Milan, Milan, Italy alessandro.invernizzi@gmail.com.

[2 ] Save Sight Institute, The University of Sydney, Faculty of Health and Medicine, Sydney, New South Wales, Australia.

[3 ] Eye Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

[4 ] Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, United States.

[5 ] Sydney Eye Hospital, Sydney, New South Wales, Australia.

[6 ] Department of Ophthalmology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

[7 ] Eye Clinic, Department of Biomedical and Clinical Science "L. Sacco", Luigi Sacco Hospital, University of Milan, Milan, Italy.

[8 ] Ocular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Article

Publisher Item ID: bjophthalmol-2019-315257

DOI: 10.1136/bjophthalmol-2019-315257

PubMed ID: 31744798

SO-VID: 4c98b5da-b16e-489d-94c1-60afdf34ffd8

History

Keywords: ranibizumab,neovascularisation,inflammatory choroidal neovascularization,inflammation,drugs,bevacizumab,aflibercept,anti-VEGF,CNV,regimen,retina,treatment,uveitis

Data availability:

Keywords: ranibizumab, neovascularisation, inflammatory choroidal neovascularization, inflammation, drugs, bevacizumab, aflibercept, anti-VEGF, CNV, regimen, retina, treatment, uveitis

Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens.

Read this article at

Abstract

Related collections

Vascular Biology

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 188

Cited by 2